NCT06420427View on ClinicalTrials.gov

Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

January 30, 2027

Conditions
cfHPV DNA in Plasma of Cervical Cancer Patients
Interventions
DIAGNOSTIC_TEST

Assess the risk of recurrence and the efficacy of medication

Evaluation of recurrence risk and medication efficacy through liquid biopsy

Trial Locations (1)

510150

RECRUITING

The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

The Third Affiliated Hospital of Guangzhou Medical University

OTHER